This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Alnylam Pharmaceuticals Inc (ALNY)

NASDAQ: Health Care

$109.07 +4.17 | 3.98%
08/28/15 - 4:00:00 PM ET
  • Prev Close: 104.90
  • Day's Open: 104.59
  • Volume: 719.68K
  • Avg Vol: 743.20K
  • Shares Outstanding: 84.62M
  • Mkt Cap: 8.65B
  • Div: --
  • Div Yield: --
  • P/E: N/A
  • EPS: -4.85
ALNY Day's Range
$104.59
$109.72
ALNY 52 Week Range
$63.4750
$140.00
ALNY Business Summary
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes novel therapeutics based on RNA interference.View ALNY key stats
Alnylam Pharmaceuticals Inc - ALNY - EQUITY
Reviewed By: TheStreet Ratings on .
Report Summary: TheStreet Ratings team rates Alnylam Pharmaceuticals Inc as a Sell with a ratings score of D+.
Report Snippet: We rate ALNYLAM PHARMACEUTICALS INC (ALNY) a SELL. This is driven by multiple weaknesses, which we believe should have a greater impact than any strengths, and could make it more difficult for investors to achieve positive results compared to most of the stocks we cover. The company's weaknesses can be seen in multiple areas, such as its unimpressive growth in net income, weak operating cash flow and feeble growth in its earnings per share.
Rating: out of 5, 'D+' Sell.
You can view the full analysis from the report here:
ALNY Rating Report
ALNY Earnings Transcripts
  • Alnylam Pharmaceuticals (ALNY) Earnings Report: Q2 2015 Conference Call Transcript
    TheStreet | 08/07/15 - 08:48 AM EDT
ALNY Performance as of Prev. Close
YTD
8.14%
3-Mo
-19.69%
1-Yr
54.13%
3-Yr
491.32%
ALNY EPS Performance
1-Yr Ago
-4.85
2-Yrs Ago
-1.45
3-Yrs Ago
-2.11
ALNY Percentage in these ETFs
0.050%
0.028%
0.012%
0.005%
0.002%
ALNY News

ALNY Alnylam Pharmaceuticals Inc

Chart of ALNY

Analysts Ratings for ALNY

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 7 7 7 7
Moderate Buy 1 1 1 1
Hold 2 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET ALNY ANALYST REPORT

Brokerage Partners

ALNY Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs